Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …

Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated
thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant …

Radioiodine ablation of thyroid tissue after subtotal thyroidectomy has been shown to
decrease recurrence in certain subsets of patients with well-differentiated thyroid cancer. In …

Radioactive iodine therapy is administered to patients with differentiated thyroid cancer
(DTC) for eradication of thyroid remnant after total thyroidectomy or, in patients with …

The procedure guideline for radioiodine (131 I) therapy and 131 I whole-body scintigraphy
of differentiated thyroid cancer in paediatric patients is the counterpart to the procedure …

Diagnostic strategy in thyroid cancer is conditioned by epidemiological, pathophysiological,
cost-effective issues changing with age and countries. Nuclear medicine has a role mainly in …

Well-differentiated thyroid carcinoma (WDTC) is predominately a surgical disease with
respect to the primary tumor, locoregional advanced disease, and the treatment of cervical …

Radioiodine scintigraphy and therapy has played a major role in the treatment and follow-up
of thyroid cancer patients for decades. Single-photon emission computed …

Post-surgical I-123 and I-131 SPECT/CT imaging can provide information on the presence
and sizes of thyroid remnants and/or metastasis for an accurate re-staging of disease to …

Traditionally, the management of differentiated thyroid cancer (DTC) in children was
approached similarly to adults. There has been a scarcity of published experience and …